The MiniMed® Paradigm™ REAL-Time insulin pump is designed to emphasise ease of use, optimise safety and ensure continuous flexible insulin delivery. Here are the benefits at a glance:
The Paradigm™ REAL-Time System was the first in the world to integrate advanced insulin pump therapy with Continuous Glucose Monitoring (CGM). It helps you cope with the challenges of controlling your diabetes, and high and low glucose levels, giving you REAL diabetes control around the clock.
It gives you the information you need to take action to control your glucose levels, preventing highs and lows, and protecting you against long-term complications. You get insights that fingersticks alone and HbA1c just can’t deliver. Now you can experience the benefits you have come to expect from insulin pump therapy – freedom from the restrictions of multiple daily injections, the flexibility to eat, sleep, and exercise how you want, when you want, and now gain REAL insights to help you take action in ways never before possible.
Part of the MiniMed® Paradigm™ family of insulin pumps, the MiniMed® Paradigm™ REAL-Time insulin pump gives you these additional benefits.
In collaboration with the Australian Government, JDRF’s Type 1 Diabetes Insulin Pump Program offers insulin pump subsidies for people under the age of 18, who meet eligibility criteria.
If you don’t meet the criteria for JDRF’s Type 1 Diabetes Insulin Pump Program, you may be eligible for Medtronic’s Patient Assistance Program.
Currently, the Australian Government offers CGM funding to children and young adults under the age of 21, who meet the eligibility criteria for the CGM Initiative. Learn more about the CGM Initiative to discover whether you’re eligible. If you’re not eligible for CGM funding, Medtronic offers a number of subscription packages, including a $50 sensor and transmitter subscription for the MiniMed® Veo™. View CGM Deals.